Lumida
/ONCT
⌘K
Oncternal Therapeutics Inc

Oncternal Therapeutics Inc

ONCT
$0.53USD-24.11%-0.17 today

MARKET CAP

1.6M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$13
STATEMENT·Income statement
USD · GAAP
METRICFY 2019FY 2020FY 2021FY 2022FY 2023TREND
Sales, Adj.$2.4M$3.4M$4.3M$1.5M$785,000
YoY %+39.2%+27.9%-65.5%-47.3%
P / Sales
EV / Sales
Gross Profit, Adj.$2.4M$3.4M$4.3M$1.5M$785,000
YoY %+39.2%+27.9%-65.5%-47.3%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit
EBITDA, Adj.$-33.1M$-17.5M$-31.4M$-44.9M$-41.7M
YoY %+47.0%-78.8%-43.3%+7.2%
Margin %-1365.3%-519.8%-726.9%-3016.6%-5313.9%
EV / EBITDA
EBIT$-33.1M$-17.5M$-31.4M$-44.9M$-41.7M
YoY %+47.0%-78.8%-43.3%+7.2%
Margin %-1365.3%-519.8%-726.9%-3016.6%-5313.9%
EV / EBIT
Net Income$-34.2M$-17.2M$-31.3M$-44.2M$-39.5M
YoY %+49.6%-81.9%-41.0%+10.6%
Net Margin-1409.8%-510.4%-726.1%-2964.4%-5029.2%
EPS (GAAP)-$66.20-$17.00-$12.80-$16.80-$13.43
YoY %+74.3%+24.7%-31.3%+20.1%